# Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC

> **NCT06864624** · PHASE2 · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 27 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Sunvozertinib

## Key facts

- **NCT ID:** NCT06864624
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-18
- **Primary completion:** 2026-12
- **Final completion:** 2029-06
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864624, "Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06864624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*